Sanofi Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Medivation
Sanofi announced that it has filed for premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with the U.S. Department of Justice Antitrust Division and the Federal Trade Commission regarding its intention to acquire Medivation, Inc. (NASDAQ: MDVN). As announced on April 28, 2016, Sanofi proposed to acquire Medivation for $52.50 per share, representing an all-cash transaction valued at approximately $9.3 billion.
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris
Jack Cox and Laurence Bollack
Tel. : +33 (0)1 53 77 46 46
Tel.: +33 (0)1 53 77 45 45
Tel.: + 1 908-981-5560